*** Welcome to piglix ***

Apolipoprotein C3

APOC3
Available structures
PDB Human UniProt search: PDBe RCSB
Identifiers
Aliases APOC3, APOCIII, HALP2, apolipoprotein C3
External IDs OMIM: 107720 HomoloGene: 81615 GeneCards: APOC3
RNA expression pattern
PBB GE APOC3 205820 s at fs.png
More reference expression data
Orthologs
Species Human Mouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000040

n/a

RefSeq (protein)

NP_000031

n/a

Location (UCSC) Chr 11: 116.83 – 116.83 Mb n/a
PubMed search n/a
ApoC-III
Identifiers
Symbol ApoC-III
Pfam PF05778
InterPro IPR008403

2JQ3

NM_000040

n/a

NP_000031

n/a

Apolipoprotein C-III also known as apo-CIII is a protein that in humans is encoded by the APOC3 gene. Apo-CIII is a component of very low density lipoprotein (VLDL).

ApoCIII is a relatively small protein containing 79 amino acids that can be glycosylated at threonine-74. The most abundant glycoforms are characterized by an O-linked disaccharide galactose linked to N-acetylgalactosamine (Gal- GalNAc), further modified with up to 2 sialic acid residues. Less abundant glycoforms are characterized by more complex and fucosylated glycan moieties.

APOC3 inhibits lipoprotein lipase and hepatic lipase; it is thought to inhibit hepatic uptake of triglyceride-rich particles. The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes. The A-I and A-IV genes are transcribed from the same strand, while the A-1 and C-III genes are convergently transcribed. An increase in apoC-III levels induces the development of hypertriglyceridemia. Recent evidences suggest an intracellular role for Apo-CIII in promoting the assembly and secretion of triglyceride-rich VLDL particles from hepatic cells under lipid-rich conditions. However, two naturally occurring point mutations in human apoC3 coding sequence, namely Ala23Thr and Lys58Glu have been shown to abolish the intracellular assembly and secretion of triglyceride-rich VLDL particles from hepatic cells.


...
Wikipedia

...